Is the glucuronide metabolite of MPA pharmacologically active?
Nowak
I
I
Department of Pathology and Laboratory Medicine, University of Pennsylvania Medical Center, Philadelphia, USA.
Wu
J
J
Brayman
K L
KL
Shaw
L M
LM
D004791:Enzyme Inhibitors / Q000494:pharmacology*; D006801:Humans; D007168:IMP Dehydrogenase / Q000037:antagonists & inhibitors*; D007700:Kinetics; D009173:Mycophenolic Acid / Q000031:analogs & derivatives* / Q000494:pharmacology*; D011994:Recombinant Proteins / Q000037:antagonists & inhibitors; D012265:Ribonucleotides / Q000494:pharmacology; D019820:Xanthine
D004791:Enzyme Inhibitors; D011994:Recombinant Proteins; D012265:Ribonucleotides; D019820:Xanthine; C011141:xanthosine monophosphate; D007168:IMP Dehydrogenase; D009173:Mycophenolic Acid